Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07419009 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Modulating Cognitive Control in OCD

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Oct 30, 2026 → Sep 30, 2027
See other at-risk trials from Dartmouth-Hitchcock Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Oct 30, 2026 to Sep 30, 2027
    • Start date: Jun 15, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 12 words
  2. Start date: Feb 15, 2026 to Jun 15, 2026
    • Primary and study completion pushed from Jun 30, 2026 to Oct 30, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study tests out procedures to look at whether a type of brain stimulation called transcranial magnetic stimulation impacts flexible shifts in behavior in obsessive-compulsive disorder (OCD). This study examines whether study procedures are feasible and acceptable to people participating in the study, but does not determine whether this type of brain stimulation causes changes.
Trial Details
NCT Number NCT07419009
Lead Sponsor Dartmouth-Hitchcock Medical Center
Conditions
(from sponsor)		 Obsessive-Compulsive Disorder (OCD)
Related terms Obsessive-Compulsive Disorder
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov